Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroendocrine Tumors 2Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoma, Merkel Cell 1Carcinoma 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

X-Rays 1Specimen Handling 1Radiation 1Photons 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Biochemically Recurrent Prostate Carcinoma × Lutetium-177 × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡